An Incisive, In-depth Analysis on the Narcolepsy Treatment Market
This study offers a comprehensive, 360 degree analysis on the Narcolepsy Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Narcolepsy Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Programmes to Increase Awareness Regarding the Importance of Narcolepsy Treatment
The burden of chronic sleep disorders, with low awareness among the general population, creates a major barrier for the growth of the narcolepsy treatment market. Policymakers require a well-coordinated approach to improve sleep-related healthcare. Increasing awareness improves the treatment and diagnosis of sleep disorders such as narcolepsy. Over the past few years, it has been observed that the number of sleep complaints has been increasing. Around 76% of the Brazilian population observed complains of sleep apnea, narcolepsy or snoring. However, despite these issues, the number of individuals seeking medical services for sleep problems did not change. This has been surging the demand for sleep treatment and thus, is expected to drive the overall narcolepsy treatment market. Moreover, increasing awareness programs are expected to effectively reduce sleep problems and increase the adoption of sleep aids, thereby boosting the narcolepsy treatment market.
Increasing Usage of Portable Sleep Apnea Devices
Sleep apnea devices such as CPAP, BiPAP and APAP are used as treatment therapies for sleep-related disorders such as narcolepsy, insomnia and others. CPAP is a medical device that comprises a pump and mask connected through a tube. The adoption of CPAP is increasing as it helps maintain proper sleep and provides relief from snoring. Companies such as Philips Respironics, ResMed, Inc. and others have increasingly been focusing on manufacturing different types of CPAP devices such as in- CPAP humidifiers, which keep the air inside the device moist. Portable CPAP devices are lighter, smaller and easier to carry and thus, people are using these devices as home-based units.
Increasing Prescription of Sleep Aids
According to CDC, around 50 to 70 Million Americans suffer from some sleep disorders and sleep deprivation conditions. Approximately 4% of the U.S. adults aged 20 and above use prescribed sleep aids. The percentage of the population using prescription sleep aids is increasing with education and age. About 9 Million U.S. adults take prescription sleep aids, wherein women (5.0%) use more prescription sleep aids than men (3.1%). This increase in the prescription of sleep aids is expected to boost the market of narcolepsy treatment globally.
Lack of Skilled Professionals and Standard Usage Guidelines
The lack of skilled healthcare professionals for operating narcolepsy treatment devices within the healthcare domain represents a prime obstacle to the growth of the narcolepsy treatment market in this region. Presently, the demand for skilled employees is rising, especially in the Middle East and Africa, due to the limited availability of resources. Furthermore, the lack of proper documentation for the usage and licensing of narcolepsy drugs and the improper equipment standardization associated with narcolepsy treatment devices hamper the growth of the global narcolepsy treatment market.
The competition section of the narcolepsy treatment market features profiles of key players operating in the industry based on their market share, product offerings for narcolepsy treatment, differential strategies, company dashboard and marketing approach. Some of the key players featured in this report include Merck & Co. Inc., Pfizer Inc., ResMed Inc., GlaxoSmithKline Plc., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Teva Pharmaceutical Industries Ltd. (Cephalon, Inc.), Jazz Pharmaceuticals plc, Mylan N.V., and others. These companies offer wide ranges of narcolepsy treatment drugs and narcolepsy treatment devices. Emerging players operating in the narcolepsy treatment market are majorly focusing on new marketing strategies in order to expand their product footprint in the global narcolepsy treatment market.
Narcolepsy is a sleep disorder categorized by overwhelming daytime drowsiness and sudden attacks of sleep. Some of the common symptoms associated with narcolepsy include excessive daytime sleepiness, loss of muscle tone, hallucinations and sleep paralysis. Obesity and lethargy are some of the complications associated with narcolepsy. Its treatment includes the use of stimulants, selective serotonin reuptake inhibitors, tricyclic antidepressants and sodium oxybate.
About the Report
The narcolepsy treatment market report offers a comprehensive evaluation of the business opportunities in the narcolepsy treatment market along with insights on the narcolepsy treatment consumer adoption process, competition blueprint, pipeline assessment, epidemiology study, list of key distributors and suppliers for the duration from 2018 to 2028.
The report offers a comprehensive taxonomy of the narcolepsy treatment market on the basis of product type, distribution channel and region. On the basis of product type, the global narcolepsy treatment market has been segmented into narcolepsy treatment drugs and devices. On the basis of distribution channel, the global narcolepsy treatment market has been segmented into retail pharmacies, hospital pharmacies, e-commerce, drug stores and others. From a geographical perspective, the narcolepsy treatment market has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA).
Additional Questions Answered
Some of the additional questions addressed in this report on narcolepsy treatment market-
What is the revenue potential of narcolepsy treatment across regions of North America and Europe?
Who are the key competitors in the narcolepsy treatment market and what are their portfolios?
What are the major challenges influencing the growth of the narcolepsy treatment market?
How is intervention from regulatory authorities shaping the narcolepsy treatment market growth?
FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information. Secondary research is used at the initial phase to identify the Age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information. Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.
Narcolepsy Treatment Market: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028
A recent market study published by the company– “Narcolepsy Treatment Market: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028” consists a comprehensive assessment of the most important market dynamics. On conducting a comprehensive research on the historic as well as current growth parameters of the narcolepsy treatment market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that are likely to have a high impact on the development of the narcolepsy treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the narcolepsy treatment market in the upcoming years. The report provides detailed information about the current and future growth prospects of the narcolepsy treatment market in the most comprehensive manner for the better understanding of readers.
Chapter 1 – Executive Summary
The report commences with the executive summary of the narcolepsy treatment market report, which includes the summary of key findings and key statistics of the narcolepsy treatment market. It also includes the market value (US$ million) estimates of the leading segments of the narcolepsy treatment market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and the definition of the narcolepsy treatment market in this chapter, which helps them understand the basic information about the narcolepsy treatment market dynamics, opportunity analysis, list of key distributors & suppliers, list of key market participants, epidemiology study, and pipeline assessment.
Chapter 3 – North America Narcolepsy Treatment Market Analysis (2013-2017) & Opportunity Assessment (2018-2028)
This chapter includes a detailed analysis of the growth of the North America narcolepsy treatment market along with a country-wise assessment that includes the U.S. and Canada. Readers can also find market growth and market attractiveness analysis based on product type, distribution channel, and country of the narcolepsy treatment in the North American region.
Chapter 4 – Latin America Narcolepsy Treatment Market Analysis (2013-2017) & Opportunity Assessment (2018-2028)
Readers can find detailed information about the growth of the Latin America narcolepsy treatment market. This chapter also includes the growth prospects of the narcolepsy treatment market in leading LATAM countries such as Brazil, Mexico and the rest of the Latin America region.
Chapter 5 – Europe Narcolepsy Treatment Market Analysis (2013-2017) & Opportunity Assessment (2018-2028)
Important growth prospects of the narcolepsy treatment market based on its product types and distribution channels in several European countries, such as EU4, UK, Russia, Poland and rest of Europe, are included in this chapter.
Chapter 6 – Asia Pacific Narcolepsy Treatment Market Analysis (2013-2017) & Opportunity Assessment (2018-2028)
India, China, Japan, ASEAN, Australia and New Zealand are the leading countries in the APAC region, which are the prime subjects of assessment to obtain the growth prospects of the APAC narcolepsy treatment market in this chapter. Readers can find detailed information about the growth parameters of the APAC narcolepsy treatment market during the period 2018-2028.
Chapter 7 – Middle East & Africa (MEA) Narcolepsy Treatment Market Analysis (2013-2017) & Opportunity Assessment (2018-2028)
This chapter provides information about how the narcolepsy treatment market will grow in the major countries in the MEA region, such as GCC Countries, South Africa and the rest of MEA, during the period 2013-2028.
Chapter 8 – Competition Landscape and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the narcolepsy treatment market along with detailed information about each company, including company overview, revenue shares, strategic overview and recent company developments. Market players featured in this report include Merck & Co. Inc., Pfizer Inc., ResMed Inc., GlaxoSmithKline Plc., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd. (Cephalon, Inc.), Jazz Pharmaceuticals plc, Mylan N.V. and others.
Chapter 9 – Global Narcolepsy Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Product Type
Based on the product type, the narcolepsy treatment market is segmented into narcolepsy treatment drugs and devices. In this chapter, readers can find information about the key trends and developments in the narcolepsy treatment market and market attractive analysis based on the product type as well as region-wise product offerings.
Chapter 10 – Global Narcolepsy Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Distribution Channel
Based on the distribution channel, the narcolepsy treatment market is segmented into hospital pharmacies, retail pharmacies, e-commerce, drug stores and others. In this chapter, readers can find information about the key trends and developments in the narcolepsy treatment market and market attractive analysis based on the distribution channel for each region.
Chapter 11 – Global Narcolepsy Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Region
This chapter explains how the narcolepsy treatment market will grow across various geographic regions, which include North America, Latin America, Europe, Asia-Pacific (APAC) and the Middle East & Africa (MEA).
Chapter 12 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 13 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information about the narcolepsy treatment market.
Narcolepsy Treatment Market Reports - Table of Contents
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
18. Assumptions and Acronyms Used
19. Research Methodology